GUARD THERAPEUTICS INTERNATIONAL

Guard Therapeutics is a Swedish biotechnology company that develops novel therapies for diseases with a great medical need for more effective treatments. Our key therapeutic area is nephrology with a focus on acute kidney injuries... Guard Therapeutics is a Swedish biotech company that identifies and develops new therapies for diseases with a great medical need for more effective treatments. The company's investigational drug RMC-035 is being developed as a kidney protective treatment in connection with open heart surgery and kidney transplantation. Guard Therapeutics is listed on Nasdaq First North Growth Market Stockholm.

Also known as: Guard Therapeutics, Guard Therapeutics AB, GUARD THERAPEUTICS INTERNATIONAL AB

Primary location: Stockholm Sweden